Datasets
- 2 results
Search results
-
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, A. C. (Creator), Saura, C. (Creator), Barroso-Sousa, R. (Creator), Guo, H. (Creator), Ciruelos, E. (Creator), Bermejo, B. (Creator), Gavilá, J. (Creator), Serra, V. (Creator), Prat, A. (Creator), Paré, L. (Creator), Céliz, P. (Creator), Villagrasa, P. (Creator), Li, Y. (Creator), Savoie, J. (Creator), Xu, Z. (Creator), Arteaga, C. L. (Creator), Krop, I. E. (Creator), Solit, D. B. (Creator), Mills, G. B. (Creator), Cantley, L. C. (Creator), Winer, E. P. (Creator), Lin, N. U. (Creator), Rodon, J. (Creator) & Prat, A. (Creator), figshare, 2020
DOI: 10.6084/m9.figshare.c.5195167, https://springernature.figshare.com/collections/Phase_2_study_of_buparlisib_BKM120_a_pan-class_I_PI3K_inhibitor_in_patients_with_metastatic_triple-negative_breast_cancer/5195167
Dataset
-
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, A. C. (Creator), Saura, C. (Creator), Barroso-Sousa, R. (Creator), Guo, H. (Creator), Ciruelos, E. (Creator), Bermejo, B. (Creator), Gavilá, J. (Creator), Serra, V. (Creator), Prat, A. (Creator), Paré, L. (Creator), Céliz, P. (Creator), Villagrasa, P. (Creator), Li, Y. (Creator), Savoie, J. (Creator), Xu, Z. (Creator), Arteaga, C. L. (Creator), Krop, I. E. (Creator), Solit, D. B. (Creator), Mills, G. B. (Creator), Cantley, L. C. (Creator), Winer, E. P. (Creator), Lin, N. U. (Creator), Rodon, J. (Creator) & Prat, A. (Creator), figshare Academic Research System, 2020
DOI: 10.6084/m9.figshare.c.5195167.v1, https://springernature.figshare.com/collections/Phase_2_study_of_buparlisib_BKM120_a_pan-class_I_PI3K_inhibitor_in_patients_with_metastatic_triple-negative_breast_cancer/5195167/1
Dataset